Share Sales
Latest news and updates related to share sales
About Share Sales coverage
The Share Sales news hub on Global Investing News tracks breaking headlines that matter to investors, policy watchers, and market strategists. Use this page to monitor how Share Sales developments affect earnings expectations, sector rotation, supply chains, regulation, and cross-asset volatility. Stories are grouped by source type — market data, company announcements, regulatory filings, and expert analysis — so you can scan the signal quickly without wading through duplicate wire copy. When a headline links to a full article, you will find expanded context, key facts, and prediction-market angles where available. Bookmark this hub if you follow Share Sales across quarters; new items are added as our crawl pipeline ingests fresh sources throughout the trading day.
Explore related topics
Latest Share Sales headlines
Market Data
(3)Philippine Bourse Chief Sees 'Mega IPOs', Share Sales
Philippine Bourse Chief Sees 'Mega IPOs', Share Sales
Indonesia Sees $11 Billion in Share Sales to Meet Free-Float Aim
Indonesia Sees $11 Billion in Share Sales to Meet Free-Float Aim
Temasek, LIC Are Said to Plan Share Sales in NSE’s India IPO
The reported plan by Temasek Holdings and Life Insurance Corporation of India (LIC) to offload stakes in the National Stock Exchange of India (NSE) marks a pivotal moment for domestic capital markets. As India’s largest stock exchange, the NSE has long been a 'unicorn' in the pre-IPO market, with its public debut delayed for years due to regulatory scrutiny regarding past governance issues and technical glitches. This secondary share sale via an Initial Public Offering (IPO) suggests that the exchange is nearing regulatory clearance from the Securities and Exchange Board of India (SEBI). For sophisticated investors, this signal indicates a thawing of the relationship between the regulator and the exchange, potentially valuing the NSE at upwards of $20 billion based on grey market premiums. The move follows a broader trend of financial lightweights like LIC monetizing non-core assets to bolster balance sheets. Investors should monitor the final offer price and the 'Offer for Sale' (OFS) structure, as no new capital will be raised for the exchange itself; rather, it provides a liquidity event for long-term institutional backers. The successful listing of the NSE would likely catalyze higher trading volumes in India and provide a direct peer-comparison valuation for the Bombay Stock Exchange (BSE), which is already publicly traded.
Other Sources
(5)Flipping Japan IPOs Loses Luster as Small Share Sales Disappear
The practice of 'flipping' initial public offerings (IPOs) in Japan, where investors quickly sell newly issued shares for a profit, is becoming less attractive. This is due to a decline in the number of small share issues, which were historically easier to 'flip' for quick gains, indicating a shift in the Japanese IPO market dynamics.
US Biotech Share Sales Deliver Biggest First Week Since 2021
Biotechnology companies in the United States have experienced a surge in share sales, achieving their strongest first-week performance since 2021. This indicates a renewed investor appetite for the sector, potentially driven by advancements in drug development or a more favorable market environment for riskier assets.
Strategy’s stock falls to fresh lows after using more share sales to buy bitcoin
MicroStrategy's stock has hit new lows as the company continues its aggressive strategy of issuing more shares to fund significant purchases of Bitcoin. This approach, while popular with some crypto investors, raises concerns among traditional investors about dilution and the highly volatile nature of Bitcoin impacting the company's core business value.
DroneShield Sets Exec Stake Policy After Share Sales Fuel Anger
Australian defense company DroneShield has implemented a new policy regarding executive shareholdings, requiring senior management to hold a minimum amount of shares in the company. This move comes after a series of share sales by executives sparked investor dissatisfaction and a perception of a lack of commitment to the company's long-term success.
Biotech Share Sales in US Deliver Biggest Quarter Since 2021
Biotechnology companies in the US have experienced their most successful quarter for share sales since 2021, indicating a renewed investor appetite for the sector. This surge in capital raising suggests increasing confidence in biotech innovation and potential future growth prospects, despite a period of market headwinds for the industry.
Get alerts for this topic
Subscribe to receive updates about "Share Sales"